Roche Gets CDSCO Panel Nod To study Anticancer FDC Pertuzumab, Trastuzumab Dr. Divya Colin25 Jun 2023 6:00 PM ISTNew Delhi: Based on the justification provided by the drug major Roche, the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Roche gets USFDA nod for Columvi to treat relapsed or refractory diffuse large B cell lymphoma Ruchika Sharma18 Jun 2023 2:42 PM ISTColumvi is a CD20xCD3 T-cell-engaging bispecific antibody designed to target CD3 on the surface of T-cells and CD20 on the surface of B-cells.
Roche cobas HPV test gets WHO prequalification Ruchika Sharma13 Jun 2023 12:15 PM ISTThe cobas HPV test detects the high-risk HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 6
Roche Holding plans to sell 800-employee drug manufacturing plant in Vacaville Ruchika Sharma4 Jun 2023 12:00 PM ISTThe company said it is seeking a buyer that will continue to use the plant as an operating facility.
USFDA accepts application for Roche Vabysmo for retinal vein occlusion treatment Ruchika Sharma9 May 2023 11:42 AM ISTRetinal vein occlusion is the second most common cause of vision loss due to retinal vascular diseases.
Roche unveils Institute of Human Biology Ruchika Sharma7 May 2023 11:30 AM ISTBasel: Roche has announced the launch of the Institute of Human Biology (IHB) focussing on advancing research in the field of human model systems such...
Hasten Biopharma acquires commercial rights for Roche's Rocephin in China Ruchika Sharma5 May 2023 5:38 PM ISTShanghai: Hasten Biopharmaceutic Co., Ltd (China) has announced that it has acquired the commercial rights in China for Rocephin from Swiss...
Roche blood cancer drug Columvi gets EMA panel recommendation for EU approval Ruchika Sharma28 April 2023 5:26 PM ISTBasel: Roche has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of...
USFDA nod to Roche's Polivy in combination with R-CHP for certain types of previously untreated diffuse large B-cell lymphoma Ruchika Sharma20 April 2023 2:30 PM ISTPolivy is a first-in-class anti-CD79b antibody-drug conjugate.
Roche collaborates with Eli Lilly to enhance early diagnosis of Alzheimer's disease Ruchika Sharma22 March 2023 3:00 PM ISTBasel: Roche has announced that it has entered into a collaboration with Eli Lilly and Company to support the development of Roche’s Elecsys Amyloid...
USFDA Committee votes in favour of clinical benefit of Roche's Polivy combination for people with previously untreated diffuse large B- cell lymphoma Ruchika Sharma13 March 2023 1:15 PM ISTPolivy is a first-in-class anti-CD79b antibody-drug conjugate.
Roche names Teresa Graham as new pharma CEO Ruchika Sharma3 Feb 2023 1:15 PM ISTBasel: Roche has announced that Teresa Graham, currently Head of Global Product Strategy for Roche Pharmaceuticals, has been appointed CEO...
